Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158


Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.

Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL.

Circ Res. 2004 Jul 23;95(2):210-6. Epub 2004 Jun 10.


Superoxide mediates the actions of angiotensin II in the central nervous system.

Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL.

Circ Res. 2002 Nov 29;91(11):1038-45.


Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-"ouabain" pathway.

Huang BS, Ahmadi S, Ahmad M, White RA, Leenen FH.

Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H422-30. doi: 10.1152/ajpheart.00256.2010. Epub 2010 May 28.


Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.

Bayorh MA, Ganafa AA, Eatman D, Walton M, Feuerstein GZ.

Am J Hypertens. 2005 Nov;18(11):1496-502.


Genetic ablation of angiotensinogen in the subfornical organ of the brain prevents the central angiotensinergic pressor response.

Sinnayah P, Lazartigues E, Sakai K, Sharma RV, Sigmund CD, Davisson RL.

Circ Res. 2006 Nov 10;99(10):1125-31. Epub 2006 Oct 19.


Chronic angiotensin II infusion modulates angiotensin II type I receptor expression in the subfornical organ and the rostral ventrolateral medulla in hypertensive rats.

Nunes FC, Braga VA.

J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):440-5. doi: 10.1177/1470320310394891. Epub 2011 Mar 10.


Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain.

Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, Davisson RL.

Circ Res. 2004 Sep 3;95(5):532-9. Epub 2004 Jul 22.


Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase.

Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH.

Circ Res. 2004 Oct 29;95(9):937-44. Epub 2004 Sep 30.


Investigation of the mechanisms by which chronic infusion of an acutely subpressor dose of angiotensin II induces hypertension.

Hood SG, Cochrane T, McKinley MJ, May CN.

Am J Physiol Regul Integr Comp Physiol. 2007 May;292(5):R1893-9. Epub 2007 Jan 25.


Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.

Hingtgen SD, Tian X, Yang J, Dunlay SM, Peek AS, Wu Y, Sharma RV, Engelhardt JF, Davisson RL.

Physiol Genomics. 2006 Aug 16;26(3):180-91. Epub 2006 May 2.


Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension.

Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG.

Circulation. 1997 Feb 4;95(3):588-93.


Effects of intracerebroventricular losartan on angiotensin II-mediated pressor responses and c-fos expression in near-term ovine fetus.

Shi L, Mao C, Thornton SN, Sun W, Wu J, Yao J, Xu Z.

J Comp Neurol. 2005 Dec 26;493(4):571-9.


Contribution of the subfornical organ to angiotensin II-induced hypertension.

Hendel MD, Collister JP.

Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H680-5. Epub 2004 Sep 30.


Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.

Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL.

J Cardiovasc Pharmacol. 2007 Jun;49(6):362-8.


Hypertension during chronic peripheral and central infusion of angiotensin III.

Fink GD, Bruner CA.

Am J Physiol. 1985 Aug;249(2 Pt 1):E201-8.


Central and peripheral renin-angiotensin systems in ouabain-induced hypertension.

Cheung WJ, Kent MA, El-Shahat E, Wang H, Tan J, White R, Leenen FH.

Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H624-30. Epub 2006 Mar 24.

Supplemental Content

Support Center